This study day, organised by The Medical Genetics Section of The Royal Society of Medicine, will provide insights and knowledge for multi-disciplinary teams in this field. DNA repair disorders represent a diagnostic challenge and are an important illustration of the challenges of caring for patients with these diseases, who need long term specialist support.
FMD is evolving from a rare disease of renal arteries accounting for a minority of cases of secondary hypertension in young women, to a "systemic" vascular disease which can affect all arterial beds. In the UK, FMD was historically thought to carry a benign prognosis. As such research in this area has lagged behind. Yet, FMD can be associated with severe hypertension, ischaemic or haemorrhagic stroke, myocardial infarction and end stage renal diseases. It can lead to invasive procedures such as percutaneous angioplasty, reconstructive surgery, or intracranial aneurysm clipping. Thus, both the disease and its treatment can lead to significant morbidity and mortality.
This information day will aim to explain what FMD is, challenge previous misconceptions about FMD and highlight the latest work being undertaken by registries and research.
We are back at The Royal Society of Medicine in London for our annual symposium held in conjunction with the wonderful Medical Genetics Section. We are looking forward to bringing you rare disease talks from patients, specialists, advocates and more. Sign up to our mailing list to make sure you don't miss out on this event or any other rare disease opportunities!
This year the annual MUMPS Conference is putting the spotlight on Rare Diseases. M4RD are working together with the MUMPS team to deliver you a brilliant day of talks and workshops. This will be a great opportunity to find out why rare diseases will be relevant to your Paediatric Specialty Training. There will also be career talks and practical workshops.
Find out more and get tickets now
#MUMPS2018 #MedEd #MedicalStudent #Paediatrics #Manchester #DareToThinkRare
A day of talks by specialists and patients on the rare disease patient perspective. Featuring 100K Genomes, access to healthcare and rare diseases in primary care.
The annual Findacure conference will bring together patient groups, clinicians, researchers, and life science professionals, to discuss the latest developments in drug repurposing, and its role in the future of rare disease treatment.
Delegates will hear examples of excellent practice of drug repurposing in rare diseases, and make connections with rare advocates in and outside of their respective fields. Prizes will also be awarded to the winners of the 2017 ‘Student Voice‘ essay competition.